GLP-1s Are Becoming More Affordable Worldwide

I want GLP-1s to be cheap. This year that started to happen. Novo Nordisk's main semaglutide patent ran out in India in March, and generic versions from several Indian drugmakers went on sale the next day. In April, Canada approved its first generic semaglutide. As it gets cheaper in more countries, I think the main thing people pay for should be the work around it, like choosing the right starting dose and knowing when to come down or stop. If the medicine cost you very little, what would you still want someone to do for you?